NAMSDL Case Law Update
Prescription drug abuse
 

This issue of NAMSDL Case Law Update focuses on several ongoing cases related to the marketing, distribution and prescribing of controlled substances. Summarized cases include: (1) a lawsuit recently filed against the maker of OxyContin by a city in Washington State and (2) a federal appellate court decision upholding a doctor’s conviction for Controlled Substances Act violations. The next issues of the Case Law Update will focus on cases involving drugged driving, marijuana and novel psychoactive substances. Read more »

Case Law Caselaw Issue Newsletter Opioid OxyContin Pharmaceutical manufacturer prescribing practices Prescription drug abuse Suspicious order Update

1